# NLCare Next-Generation Gap Analysis

Generated from repository artifacts at `2026-08-11T06:52:48.637751+00:00`.

> NLCare remains synthetic-only, non-diagnostic, not clinically validated, and not production healthcare ready. Internal tests are engineering evidence, not evidence of patient benefit or medical effectiveness.

## Current state

NLCare has a mature portfolio-grade safety and evaluation surface: deterministic and semantic boundaries, source-governed RAG, bounded tool workflows, tenant-aware SaaS scaffolding, synthetic temporal ML, observability, and release gates.

## Existing strengths

- Frozen dataset integrity failures: `0`.
- Internal post-change adversarial mutation pass rate: `1.0`; this bank is tuning-used.
- Tenant security: `passed`.
- Corpus poisoning: `passed`.
- The codebase preserves negative RAG findings instead of promoting complexity by default.

## Confirmed weaknesses

- Existing v7 internal holdout pass rate remains `0.676056` and was already inspected.
- Independently authored external evaluation: `BLOCKED_EXTERNAL`.
- Section-aware live promotion: `False`.
- Dense serving is available locally, but the restricted Docker profile remains sparse until quality and latency evidence justify promotion.
- No clinician, nurse, or genetic counselor review has been completed.

## Technical debt and risk

- Multiple historical eval artifacts overlap in cases, so consolidated attribution reports both raw rows and unique case-stage counts.
- Process-local load measurements isolate planner concurrency and cannot substitute for network/provider/DB load.
- The synthetic ML layer demonstrates engineering discipline but cannot establish clinical realism or transfer.
- A large release-gate inventory can dilute attention; critical blockers must remain distinct from informational scaffolds.

## External blockers

- Independently authored no-read RAG and adversarial cases.
- Oncology clinician or nurse wording/safety review.
- Genetics-qualified VUS review.
- Managed-cloud credentials, independent security review, and non-synthetic traffic evidence.
- Real-data or patient-facing work would require institutional governance and appropriate ethics/IRB pathways.

## Implementation order

1. Preserve frozen hashes and complete external no-read authoring.
2. Adjudicate patient-facing versus clinician-facing source expectations.
3. Optimize only failure buckets with enough mass and verify on untouched data.
4. Run managed synthetic staging, backup/restore, and distributed load drills.
5. Convert accepted human findings into versioned regression tests.
